Alpha Paradigm Partners’s Pfizer PFE Stock Holding History

Alpha Paradigm Partners’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-19,653	Closed	-$860K	–	583
2022 Q3	$860K	Buy	+19,653	New	+$955K	0.37%	81
2022 Q1	–	Sell	-14,443	Closed	-$853K	–	654
2021 Q4	$853K	Sell	14,443 -28,222	-66%	-$1.4M	0.34%	83
2021 Q3	$1.83M	Buy	42,665 +36,904	+641%	+$1.63M	0.74%	17
2021 Q2	$226K	Buy	+5,761	New	+$224K	0.09%	337

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Alpha Paradigm Partners's PFE Position: Q4 2022 in Review

Alpha Paradigm Partners sold out of Pfizer (PFE) in Q4 2022, closing a stake of 19,653 shares — an estimated $860K sold.

Alpha Paradigm Partners first reported a position in PFE in Q2 2021 and held it in 4 quarters. The position peaked at $1.83M in Q3 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

Alpha Paradigm Partners reported no remaining Pfizer position as of Q4 2022 after selling out during the quarter.
Alpha Paradigm Partners sold 19,653 Pfizer shares in Q4 2022, an estimated $860K.
Alpha Paradigm Partners first reported a position in Pfizer in Q2 2021 and held it in 4 quarters.
Alpha Paradigm Partners's Pfizer position peaked at $1.83M in Q3 2021.
3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Alpha Paradigm Partners's 13F filing for Q4 2022, filed 13 Feb 2023.